Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

Bullboard Posts
Post by bullboardmonkeyon May 27, 2015 4:31pm
186 Views
Post# 23771191

Welcome To The Ventripoint Conundrum

Welcome To The Ventripoint ConundrumFor those new to the bullboard who are perplexed by the well above average volume that has been traded lately and the stagnant share price reaction, I can only say that Ventripoint has greatly increased its marketability potential over the past few years, however have never produced any significant sales to validate all their claims. Management predicted that the company would be cash flow positive from sales by the end of 2012. Until actual significant sales figures appear in our financials, I doubt we will see any sustained share price positive movement. With lack of sales, the continuous financings that were required to keep us afloat over the past years have dragged our share price to the level it sits today.
Perhaps we are gathering momentum that will break us free from our constraints; however, I would not "bet the farm" that it will happen anytime soon.


Bullboard Posts